NM_001005361.3:c.161+9407G>A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001005361.3(DNM2):​c.161+9407G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0837 in 152,110 control chromosomes in the GnomAD database, including 564 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.084 ( 564 hom., cov: 32)

Consequence

DNM2
NM_001005361.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.612

Publications

25 publications found
Variant links:
Genes affected
DNM2 (HGNC:2974): (dynamin 2) Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]
DNM2 Gene-Disease associations (from GenCC):
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease dominant intermediate B
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant Charcot-Marie-Tooth disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fetal akinesia-cerebral and retinal hemorrhage syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary spastic paraplegia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNM2NM_001005361.3 linkc.161+9407G>A intron_variant Intron 1 of 20 ENST00000389253.9 NP_001005361.1 P50570-4Q8N1K8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNM2ENST00000389253.9 linkc.161+9407G>A intron_variant Intron 1 of 20 5 NM_001005361.3 ENSP00000373905.4 P50570-4

Frequencies

GnomAD3 genomes
AF:
0.0837
AC:
12718
AN:
151992
Hom.:
564
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.0576
Gnomad ASJ
AF:
0.0926
Gnomad EAS
AF:
0.0458
Gnomad SAS
AF:
0.104
Gnomad FIN
AF:
0.0478
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.0816
Gnomad OTH
AF:
0.0836
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0837
AC:
12732
AN:
152110
Hom.:
564
Cov.:
32
AF XY:
0.0804
AC XY:
5980
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.108
AC:
4480
AN:
41476
American (AMR)
AF:
0.0575
AC:
878
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0926
AC:
321
AN:
3466
East Asian (EAS)
AF:
0.0459
AC:
238
AN:
5182
South Asian (SAS)
AF:
0.104
AC:
498
AN:
4806
European-Finnish (FIN)
AF:
0.0478
AC:
506
AN:
10576
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0816
AC:
5552
AN:
68012
Other (OTH)
AF:
0.0832
AC:
176
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
608
1217
1825
2434
3042
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0789
Hom.:
1567
Bravo
AF:
0.0856
Asia WGS
AF:
0.0890
AC:
311
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
17
DANN
Benign
0.81
PhyloP100
0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11671653; hg19: chr19-10838486; API